Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.61 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.61 |
| ▸ | CLCN2 | P51788 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.44 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.44 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5696553 | 0.84 | GABRA1 (0.61) | GABRA1GABRB2CLCN2ALDH1A1KDM4E | |
| SCHEMBL625116 | 0.84 | NR4A1 (0.48) | GABRA1GABRB2CLCN2ALDH1A1HMGB1 | |
| SCHEMBL4377020 | 0.84 | ALDH1A1 (0.44) | GABRA1GABRB2CLCN2ALDH1A1HMGB1 | |
| SCHEMBL27747091 | 0.84 | BID (0.49) | GABRA1GABRB2CLCN2HMGB1ALOX15 | |
| SCHEMBL6828930 | 0.83 | ALDH1A1 (0.48) | GABRA1GABRB2CLCN2ALDH1A1HMGB1 | |
| SCHEMBL28551512 | 0.82 | HMGB1 (0.43) | GABRA1GABRB2CLCN2ALDH1A1HMGB1 | |
| SCHEMBL27598816 | 0.82 | GABRA1 (0.59) | GABRA1GABRB2CLCN2ALDH1A1HTT | |
| SCHEMBL16416766 | 0.82 | HMGB1 (0.51) | GABRA1GABRB2CLCN2ALDH1A1HMGB1 | |
| SCHEMBL28204006 | 0.82 | GABRA1 (0.59) | GABRA1GABRB2CLCN2ALDH1A1KDM4E | |
| SCHEMBL21121083 | 0.82 | MGLL (0.46) | GABRA1GABRB2CLCN2ALDH1A1HMGB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3805337-B1 | INK COMPOSITIONS AND QUANTUM DOT POLYMER COMPOSITE PATTERN PREPARED FROM THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2023-08-09 | — | — | EP | disclosed |
| US-11248139-B2 | Ink compositions and quantum dot polymer composite pattern prepared from the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-02-15 | — | — | US | disclosed |
| EP-3805337-A1 | INK COMPOSITIONS AND QUANTUM DOT POLYMER COMPOSITE PATTERN PREPARED FROM THE SAME | Samsung Display Co., Ltd. (KR) | 2021-04-14 | — | — | EP | disclosed |
| US-20210102084-A1 | INK COMPOSITIONS AND QUANTUM DOT POLYMER COMPOSITE PATTERN PREPARED FROM THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-04-08 | — | — | US | disclosed |
| EP-1718682-B1 | PREPARATION METHOD OF SOLID TITANIUM CATALYST FOR OLEFIN POLYMERIZATION | HANWHA TOTAL PETROCHEMICAL CO LTD (KR) | 2019-03-27 | — | — | EP | disclosed |
| EP-3029026-B1 | NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME | DONG A ST CO LTD (KR) | 2018-12-05 | — | — | EP | disclosed |
| US-9828339-B2 | Biphenyl derivatives and methods for preparing same | DONG-A ST CO., LTD (KR) | 2017-11-28 | — | — | US | disclosed |
| US-20160176816-A1 | NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME | DONG-A ST CO., LTD (KR) | 2016-06-23 | — | — | US | disclosed |
| EP-3029026-A1 | NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME | Dong-A ST Co., Ltd. (KR) | 2016-06-08 | — | — | EP | disclosed |
| WO-2011009484-A1 | ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS | NOVARTIS AG (CH) | 2011-01-27 | — | — | WO | disclosed |
| WO-1996039374-A1 | 2,4-PENTADIENOIC ACID DERIVATIVES HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY | ALLERGAN (US) | 1996-12-12 | — | — | WO | disclosed |
| US-5374615-A | Treating hypertension and congestive heart failure, preventing cardiac hypertrophy | E. R. SQUIBB & SONS, INC. (US) | 1994-12-20 | — | — | US | disclosed |
| EP-0488532-A1 | Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives | E.R. Squibb & Sons, Inc. (US) | 1992-06-03 | — | — | EP | disclosed |
| US-4873278-A | Inhibition of irradiation yellowing in polysulfone compositions | GENERAL ELECTRIC COMPANY (US) | 1989-10-10 | — | — | US | disclosed |
| US-4303766-A | SULFONATION OF ELASTOMERS, FRIEDEL-CRAFTS OR COORDINATION CATALYST, ACYL SULFATE, QUENCHING, NEUTRALIZATION | EXXON RESEARCH & ENGINEERING CO. (US) | 1981-12-01 | — | — | US | disclosed |
| EP-0002354-B1 | A PROCESS FOR SULPHONATING ELASTOMERIC POLYMERS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1981-05-20 | — | — | EP | disclosed |
| US-4193901-A | WITH A MIXTURE OF A SULFUR TRIOXIDE-LEWIS BASE COMPLEX AND A CARBOXYLIC ANHYDRIDE OR ACYL HALIDE | EXXON RESEARCH & ENGINEERING CO. (US) | 1980-03-18 | — | — | US | disclosed |
| US-4162241-A | NEUTRALIZED SULFONATED BUTYL RUBBER OR DIENE-ETHYLENE-PROPYLENE TERPOLYMER | EXXON RESEARCH & ENGINEERING CO. (US) | 1979-07-24 | — | — | US | disclosed |
| EP-0002354-A1 | A process for sulphonating elastomeric polymers | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1979-06-13 | — | — | EP | disclosed |
| US-4105647-A | SOLUTION POLYMERIZATION USING A FRIEDEL-CRAFTS OF ZIEGLER-TYPE CATALYST | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160176816-A1 | NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME | CHRM2, CHRM3, CHRM5 | GABRA1 167/4885GABRB2 136/4885CLCN2 1387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.